Philipp Bahrmann
Research Subjects
Philipp Bahrmann has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Cornel Christian Sieber
Institute for Biomedicine of Aging Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Nürnberg Germany
4 shared publications Michael Christ
3 shared publicationsThomas Bertsch
3 shared publicationsAnke Bahrmann
2 shared publicationsHans-Juergen Heppner
Institute for Biomedicine of Ageing, Friedrich-Alexander-University Erlangen-Nuremberg, Nuremberg, Germany
2 shared publicationsAmelie Abel
Bethanien Hospital, Geriatric Centre of the University of Heidelberg, Germany
1 shared publication
Latest Publications
- 1 March 2014
- Published by Elsevier in Patient Education and Counseling
- Vol. 94 (3) , 417-422
Psychological insulin resistance in geriatric patients with diabetes mellitus
- 1 March 2014
- Published by Elsevier in Patient Education and Counseling
- Vol. 94 (3) , 417-422
Psychological insulin resistance in geriatric patients with diabetes mellitus
- 1 March 2013
- Published by Springer Nature in MMW - Fortschritte der Medizin
- Vol. 155 (5) , 67-69
Lebensverlängerung ja, Demenzschutz wahrscheinlich
- 1 March 2013
- Published by Springer Nature in MMW - Fortschritte der Medizin
- Vol. 155 (5) , 67-69
Lebensverlängerung ja, Demenzschutz wahrscheinlich
- 9 January 2013
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 51 (6) , 1307-1319
Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department1)
Background: Identifying older patients with non-ST- elevation myocardial infarction (NSTEMI) within the very large proportion with elevated high-sensitive cardiac troponin T (hs-cTnT) is a diagnostic challenge because they often present without clear symptoms or electrocardiographic features of acute coronary syndrome to the emergency department (ED). We prospectively investigated the diagnostic and prognostic performance of copeptin ultra-sensitive (copeptin-us) and hs-cTnT compared to hs-cTnT alone for NSTEMI at prespecified cut-offs in unselected older patients. Methods: We consecutively enrolled 306 non-surgical patients ≥70 years presenting to the ED. In addition to clinical examination, copeptin-us and hs-cTnT were measured at admission. Two cardiologists independently adjudicated the final diagnosis of NSTEMI after reviewing all available data. All patients were followed up for cardiovascular-related death within the following 12 months. Results: NSTEMI was diagnosed in 38 (12%) patients (age 81±6 years). The combination of copeptin-us ≥14 pmol/L and hs-cTnT ≥0.014 µg/L compared to hs-cTnT ≥0.014 µg/L alone had a positive predictive value of 21% vs. 19% to rule in NSTEMI. The combination of copeptin-us Conclusions: In unselected older patients presenting to the ED, the additional use of copeptin-us at predefined cut-offs may help to reliably rule out NSTEMI but may not help to increase predicted risk for outcome compared to hs-cTnT alone.
- 9 January 2013
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 51 (6) , 1307-1319
Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department1)
Background: Identifying older patients with non-ST- elevation myocardial infarction (NSTEMI) within the very large proportion with elevated high-sensitive cardiac troponin T (hs-cTnT) is a diagnostic challenge because they often present without clear symptoms or electrocardiographic features of acute coronary syndrome to the emergency department (ED). We prospectively investigated the diagnostic and prognostic performance of copeptin ultra-sensitive (copeptin-us) and hs-cTnT compared to hs-cTnT alone for NSTEMI at prespecified cut-offs in unselected older patients. Methods: We consecutively enrolled 306 non-surgical patients ≥70 years presenting to the ED. In addition to clinical examination, copeptin-us and hs-cTnT were measured at admission. Two cardiologists independently adjudicated the final diagnosis of NSTEMI after reviewing all available data. All patients were followed up for cardiovascular-related death within the following 12 months. Results: NSTEMI was diagnosed in 38 (12%) patients (age 81±6 years). The combination of copeptin-us ≥14 pmol/L and hs-cTnT ≥0.014 µg/L compared to hs-cTnT ≥0.014 µg/L alone had a positive predictive value of 21% vs. 19% to rule in NSTEMI. The combination of copeptin-us Conclusions: In unselected older patients presenting to the ED, the additional use of copeptin-us at predefined cut-offs may help to reliably rule out NSTEMI but may not help to increase predicted risk for outcome compared to hs-cTnT alone.
- 14 September 2012
- Published by Springer Nature in Notfall + Rettungsmedizin
- Vol. 16 (4) , 284-290
Diagnostische Abklärung des akuten Koronarsyndroms bei älteren Patienten in der Notaufnahme
- 14 September 2012
- Published by Springer Nature in Notfall + Rettungsmedizin
- Vol. 16 (4) , 284-290
Diagnostische Abklärung des akuten Koronarsyndroms bei älteren Patienten in der Notaufnahme
- 1 June 2012
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 24 (3) , 290-294
Early detection of non-ST-elevation myocardial infarction in geriatric patients by a new high-sensitive cardiac troponin T assay
- 1 June 2012
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 24 (3) , 290-294
Early detection of non-ST-elevation myocardial infarction in geriatric patients by a new high-sensitive cardiac troponin T assay